Valeo Pharma (TSX:VPH) Accumulated Depreciation : C$-1.31 Mil (As of Jan. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Valeo Pharma Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Valeo Pharma's quarterly accumulated depreciation increased from Jul. 2023 (C$-1.05 Mil) to Oct. 2023 (C$-1.21 Mil) and increased from Oct. 2023 (C$-1.21 Mil) to Jan. 2024 (C$-1.31 Mil).

Valeo Pharma's annual accumulated depreciation increased from Oct. 2021 (C$-0.60 Mil) to Oct. 2022 (C$-0.84 Mil) and increased from Oct. 2022 (C$-0.84 Mil) to Oct. 2023 (C$-1.21 Mil).

Valeo Pharma Accumulated Depreciation Historical Data

The historical data trend for Valeo Pharma's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valeo Pharma Accumulated Depreciation Chart

Valeo Pharma Annual Data

Trend

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Accumulated Depreciation

Get a 7-Day Free Trial

-0.48

-0.58

-0.60

-0.84

-1.21

Valeo Pharma Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Accumulated Depreciation	Get a 7-Day Free Trial															-0.91	-0.98	-1.05	-1.21	-1.31

Valeo Pharma Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Valeo Pharma Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Valeo Pharma's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Valeo Pharma (TSX:VPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valeo Pharma Inc (TSX:VPH) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

VPHIF:USA

Address

16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9

Website

https://www.valeopharma.com

Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and Niche hospital injectable products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.

Executives

Luc Mainville

Senior Officer

Valeo Pharma (TSX:VPH) Headlines

No Headlines